Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
The role of SLAMF7 in multiple myeloma: impact on therapy.
Boudreault JS, Touzeau C, Moreau P. Boudreault JS, et al. Expert Rev Clin Immunol. 2017 Jan;13(1):67-75. doi: 10.1080/1744666X.2016.1209112. Epub 2016 Jul 18. Expert Rev Clin Immunol. 2017. PMID: 27376202 Review.
Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14).
Touzeau C, Le Gouill S, Mahé B, Boudreault JS, Gastinne T, Blin N, Caillon H, Dousset C, Amiot M, Moreau P. Touzeau C, et al. Among authors: boudreault js. Haematologica. 2017 Mar;102(3):e112-e114. doi: 10.3324/haematol.2016.160408. Epub 2017 Jan 5. Haematologica. 2017. PMID: 28057737 Free PMC article. No abstract available.
Bendamustine-induced nephrogenic diabetes insipidus - A case report.
Desjardins A, Le-Nguyen V, Turgeon-Mallette L, Vo C, Boudreault JS, Rioux JP, Feng X, Veilleux A. Desjardins A, et al. Among authors: boudreault js. J Oncol Pharm Pract. 2021 May 14:10781552211013878. doi: 10.1177/10781552211013878. Online ahead of print. J Oncol Pharm Pract. 2021. PMID: 33990157